A phase III open clinical study of SJP-0118 in patients who schedule intraocular surgery
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 06 Sep 2017
At a glance
- Drugs SJP 0118 (Primary)
- Indications Infectious conjunctivitis
- Focus Therapeutic Use
- Sponsors Senju Pharmaceutical
- 05 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 13 Apr 2017 Status changed from not yet recruiting to recruiting.
- 21 Mar 2017 New trial record